CorVel Corporation — Form 10-Q summary
Period note: The request metadata says “2015 Q2,” but the filing is for the quarter ended September 30, 2016 (CorVel fiscal 2017 second quarter), with comparisons to the three and six months ended September 30, 2015.
Business context and reporting period
CorVel provides workers’ compensation and auto-claims medical cost containment and managed-care services, including network solutions and patient management. It reports one operating segment. The filing is unaudited and covers the quarter and six months ended September 30, 2016.
Key financial metrics
| Metric | Quarter ended Sep. 30, 2016 | Six months ended Sep. 30, 2016 |
|---|---|---|
| Revenue | $128.2 million | $256.7 million |
| Gross profit / margin | $25.9 million / 20.2% | $51.5 million / 20.1% |
| Income before taxes | $11.3 million | $23.4 million |
| Net income | $7.0 million | $14.4 million |
| Diluted EPS | $0.35 | $0.73 |
| Operating cash flow | Not separately provided for the quarter | $20.5 million |
At September 30, 2016, cash and cash equivalents were $40.9 million, working capital was $52.1 million, total assets were $240.2 million, and total liabilities were $94.1 million. The company reported no debt outstanding. Its renewed revolving credit facility provides up to $10 million and expires in September 2017; the company was covenant-compliant. Outstanding letters of credit totaled $4.5 million and, according to the filing, do not reduce facility availability.
Changes versus prior comparable periods
- Quarterly revenue rose 3.0% year over year, while net income fell 15.9% and diluted EPS declined from $0.41 to $0.35. Gross margin declined from 21.4% to 20.2%.
- Six-month revenue increased 2.1%, while net income decreased 4.8% and diluted EPS fell from $0.75 to $0.73. Gross margin declined from 21.0% to 20.1%.
- Patient management drove most revenue growth, with higher TPA services partly offset by lower case-management services. Management attributed margin pressure to growth in lower-margin TPA work, weaker case-management margins, and increased salaries, directed-network costs, and temporary help.
- Quarterly general and administrative expense rose 10.9%, partly from legal, information-systems, and marketing spending. For the six-month period it was nearly flat versus the prior year.
- Six-month operating cash flow declined from $24.6 million to $20.5 million, which management primarily attributed to changes in prepaid taxes and expenses. Capital expenditures increased to $10.8 million from $8.0 million, partly due to software-license renewals.
- Cash increased by $8.1 million from March 31, 2016. Management attributed the increase partly to reduced share repurchases; six-month repurchases were $4.2 million versus $18.8 million in the prior-year period.
Outlook, risks, contingencies and unusual items
- Management said cash, expected operating funds, and the credit facility should cover expected requirements for at least the next twelve months. No specific revenue or earnings guidance was provided.
- Management noted the long-term decline in U.S. workplace injury rates, which may reduce claims demand. Other disclosed risks include competition, customer insourcing or contract losses, labor costs and staffing, regulatory changes, litigation, cybersecurity and system interruptions, and dependence on key personnel.
- Contractual obligations totaled $55.5 million, including $49.8 million of operating leases, $3.5 million of software-license obligations, and $2.2 million related to uncertain tax positions.
- Management characterized ordinary-course litigation as not expected to result in material payments. It reported no identified impairment indicators for goodwill or long-lived assets at September 30, 2016.
- After quarter-end, the company repurchased 61,880 shares for $2.2 million at an average $35.51 per share. The filing also reports $4.2 million of repurchases during the six-month period.
- The filing states disclosure controls were effective and there were no material changes in internal control over financial reporting during the quarter.
Important facts for investors to verify
- Confirm the intended filing period: the supplied filing is for September 30, 2016, not 2015.
- Track whether patient-management growth, particularly TPA services, improves or further dilutes margins, and whether case-management performance stabilizes.
- Review operating cash conversion, software-related capital spending, and the scale and pricing of ongoing share repurchases.
- Monitor the September 2017 credit-facility renewal, covenant compliance, and the company’s ability to meet lease and other contractual commitments.
- Assess whether declining workplace injury rates, competition, litigation costs, and labor pressures materially affect demand or profitability.